- We are working hard to come back as soon as possible.
- Nous travaillons dur pour revenir au plus vite.
- Wir arbeiten hart daran, so schnell wie möglich zurückzukommen
- Estamos trabajando duro para volver lo antes posible.
- Stiamo lavorando sodo per tornare il prima possibile.
- Wij werken hard om zo snel mogelijk weer terug te zijn.
Robert Iannone
Chief Tech/Sci/R&D Officer bij JAZZ PHARMACEUTICALS PLC
Vermogen: 7 M $ op 30-04-2024
Actieve functies van Robert Iannone
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Chief Tech/Sci/R&D Officer | 29-05-2019 | - |
| ITEOS THERAPEUTICS, INC. | Director/Board Member | 03-05-2021 | - |
| Independent Dir/Board Member | 03-05-2021 | - | |
| AUTOLUS THERAPEUTICS PLC | Director/Board Member | 20-06-2023 | - |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Chief Tech/Sci/R&D Officer | 01-05-2019 | - |
Loopbaan van Robert Iannone
Eerdere bekende functies van Robert Iannone
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| JOUNCE THERAPEUTICS, INC. | Director/Board Member | 21-01-2020 | 03-05-2023 |
| Independent Dir/Board Member | 21-01-2020 | 03-05-2023 | |
| IMMUNOMEDICS, INC. | Chief Tech/Sci/R&D Officer | 09-04-2018 | 28-05-2019 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01-07-2014 | 01-04-2018 |
| MERCK & CO., INC. | Director/Board Member | 01-03-2008 | 01-07-2014 |
| Corporate Officer/Principal | 01-03-2008 | 01-07-2014 | |
| University of Pennsylvania Medical Center | Corporate Officer/Principal | 01-01-2001 | 01-01-2012 |
Opleiding van Robert Iannone
| The Catholic University of America | Undergraduate Degree |
| Yale University | Doctorate Degree |
| University of Pennsylvania Medical Center | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 9 |
| Verenigd Koninkrijk | 3 |
| Ierland | 2 |
Operationeel
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 3 |
Sectoraal
| Health Technology | 8 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| ITEOS THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
- Beurs
- Insiders
- Robert Iannone
- Ervaring
